Your about to leave the site and are being redirected to another site. Would you like to leave this site?

Click for Additional Indications

1 of 2

INDICATIONS

Merkel Cell Carcinoma

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma. BAVENCIO may be used when your skin cancer has spread.

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

Click for Additional Indications

2 of 2

INDICATIONS

Urothelial Cancer

BAVENCIO® (avelumab) is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial cancer. BAVENCIO may be used when your cancer:

  • Has spread or cannot be removed by surgery (advanced urothelial cancer), and
  • You have received chemotherapy that contains a platinum-containing drug and it did not work or is no longer working

This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

For patients with a type of skin cancer called

MERKEL CELL CARCINOMA (MCC) that has spread

For certain previously treated patients with

a type of cancer in the bladder or urinary tract called UROTHELIAL CARCINOMA (UC)

that has spread or cannot be removed by surgery